GSDMD inhibitors include disulfiram (used to treat alcohol addiction), C202-2729, teriflunomide, and necrosulfonamide, which inhibits GSDMD pore formation, pyroptosis and IL-1β release in cell and mouse models [42,82–84]. This evidence concerns the gene GSDMD and Addictive alcohol use.